World Federation of Neurology News

WFN invites bids to host WCN 2027 in the Africa and Pan Arab Regions

12 Aug 2022

The WFN looks forward to hearing from any member neurological society in the African and Pan Arab regions that wish to be considered as the host of WCN 2027.

Montreal Department Visit Program 2022

4 Aug 2022

The World Federation of Neurology (WFN) and The Montreal Neurological Institute-Hospital (The Neuro), together with the Canadian Neurological Society (CNS), are pleased to invite two colleagues from Central or South America, and one neurology trainee or junior faculty from Africa to visit the Neurology Department of The Neuro at McGill University in Quebec, Canada.

Journal of the Neurological Sciences issue 439 now available

31 Jul 2022

Vol. 439, August 2022 now available

World Neurology: May/Junel issue now available online

21 Jul 2022

The issue begins with the President's Column, where WFN President Dr. Wolfgang Grisold updates on many of the current and evolving global activities, major events, and projects that the WFN is involved in. Kimberly Karlshoej, WFN strategy and program director, updates us on the Intersectorial Global Action Plan on Epilepsy and Other Neurologic Disorders (IGAP) 2022-2031 and its recent adoption by the World Health Assembly.

World Brain Day 2022 Will Feature Leading Experts to Promote Brain Health

19 Jul 2022

July 22 is devoted to Brain Health for All for World Brain Day (WBD). This year, in a free webinar, the World Federation of Neurology (WFN) is featuring leading experts from regional and global organizations who are prioritizing brain health, including the World Health Organization (WHO).

COVID-19 July Update

7 Jul 2022

In this month’s Neurology and COVID-19 review, we’ve included several topics that have arisen in the literature and news, including new updates regarding long COVID/PASC and neurologic outcomes of infants born to mothers with COVID-19.

Post-acute Sequelae of SARS-CoV-2 (PASC) or long COVID continues to be a puzzling entity; however, numerous new studies are underway to help better understand the nature of this syndrome and the mechanisms involved in its pathogenesis, including neurologic aspects. This month, the initial findings from the University of San Diego NeuCOVID longitudinal cohort study was published, describing the neurologic manifestations in two cohorts: patients referred to the  Neurology department after recovering from COVID-19, and patients with pre-existing neurologic disorders who subsequently were diagnosed with COVID-19.  In this cohort of 56 patients, fatigue was the most commonly reported symptom at baseline (89.3%), followed by headache (80.4%), insomnia (66.1%), and memory impairment (64.3%).

eNeurologicalSci (eNS) June 2022 issue

20 Jun 2022

The WFN June 2022 issue of the OPEN ACCESS journal eNeurologicalSci Vol. 27 is now available online.

The Intersectoral Global Action Plan on Epilepsy and other Neurological Disorders Adopted at WHO’s World Health Assembly

27 May 2022

The adoption of IGAP results from years of work and consultations with WFN, other members of the Global Neurological Alliance, the WHO Secretariat and the Member States.

WFN Elections 2022: Nominating Committee Recommendations

26 May 2022

Recommendations of the WFN Nominating Committee for Secretary General and Elected Trustee posts falling vacant with effect from the 2022 Annual General Meeting (Council of Delegates)